SHP Wealth Management’s Labcorp LH Stock Holding History

SHP Wealth Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.8K	Buy	164 +4	+3%	+$1.08K	﹤0.01%	525
2025 Q4	$40.1K	Buy	+160	New	+$42.5K	﹤0.01%	531

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SHP Wealth Management's LH Position: Q1 2026 in Review

SHP Wealth Management increased its Labcorp (LH) stake by 2.5% in Q1 2026, buying an estimated $1.08K and bringing the position to 164 shares worth $43.8K. The position accounts for ﹤0.01% of the portfolio, ranked #525.

SHP Wealth Management first reported a position in LH in Q4 2025 and has held it in 2 quarters since. 1,034 funds tracked by Wall St. Rank hold LH as of Q1 2026.

SHP Wealth Management held 164 shares of Labcorp worth $43.8K as of Q1 2026.
SHP Wealth Management bought 4 Labcorp shares in Q1 2026, an estimated $1.08K.
Labcorp made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #525 holding.
SHP Wealth Management first reported a position in Labcorp in Q4 2025 and has held it in 2 quarters since.
1,034 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.